Immunogenicity of a recombinant measles-HIV-1 clade B candidate vaccine.
Stebbings R, Février M, Li B, Lorin C, Koutsoukos M, Mee E, Rose N, Hall J, Page M, Almond N, Voss G, Tangy F.
Stebbings R, et al. Among authors: page m.
PLoS One. 2012;7(11):e50397. doi: 10.1371/journal.pone.0050397. Epub 2012 Nov 30.
PLoS One. 2012.
PMID: 23226275
Free PMC article.